GT Biopharma, Inc. (GTBP) Tops Q3 EPS by 3c

GT Biopharma, Inc. (NASDAQ: GTBP) reported Q3 EPS of ($0.06), $0.03 better than the analyst estimate of ($0.09).

For earnings history and earnings-related data on GT Biopharma, Inc. (GTBP) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Blue Owl keeps 5% redemption caps as OCIC requests ease from prior quarter
• SAS CEO van der Werff emerges as frontrunner for Air Canada top job - Bloomberg